1-207761338-T-G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_172351.3(CD46):c.565T>G(p.Tyr189Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000205 in 1,612,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_172351.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251434Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135896
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1460174Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 726582
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:2
- -
Variant summary: CD46 c.565T>G (p.Tyr189Asp) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251434 control chromosomes. c.565T>G has been reported in the literature in individuals affected with Genetic Atypical Hemolytic Uremic Syndrome including at-least one patient at a homozygous state (Wang_2024), in other occurrences, the variant was often reported along with variant(s) from other genes or without detailed information (Bacchi_2006, Brackman_2011, Ardissino_2021, Rydberg_2023, Brocklebank_2023). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in non-detectable C3b or C4b binding activity and negligible cofactor activity in CHO cells (Bacchi_2006). The following publications have been ascertained in the context of this evaluation (PMID: 21810760, 34169201, 23307876, 37369098, 37744338, 39097532). ClinVar contains an entry for this variant (Variation ID: 988106). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Atypical hemolytic-uremic syndrome Pathogenic:1
This patient is heterozygous for a variant in CD46, c.565T>G, which is predicted to cause an amino acid substitution p.Tyr189Asp. This variant has been previously reported either as a single heterozygous variant or in conjunction with other CD46 variants, in aHUS patients (Fremeaux-Bacchi et al. 2006. J Am Soc Nephrol 17:2017-2025; Bu et al. 2014. J Am Soc Nephrol 25: 55-64). Patients with the c.565T>G variants had decreased levels of the protein product MCP, and the function of p.Tyr189Asp mutant MCP was also shown to be decreased in vitro (Fremeaux-Bacchi et al. 2006). c.565T>G has been reported in the ExAC database (http://exac.broadinstitute.org) with a very low allele frequency (1/121036 alleles). This variant is considered to be a likely pathogenic according to the ACMG guidelines. -
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly Uncertain:1
- -
not provided Uncertain:1
This sequence change replaces tyrosine, which is neutral and polar, with aspartic acid, which is acidic and polar, at codon 189 of the CD46 protein (p.Tyr189Asp). This variant is present in population databases (rs202071781, gnomAD 0.005%). This missense change has been observed in individual(s) with atypical hemolytic uremic syndrome (aHUS), however some individuals also carried variants in other aHUS-causing genes (PMID: 16762990, 20059470, 20513133, 21810760, 23314101, 24029428, 29644059, 33213850, 34169201). This variant is also known as Y155D in the MCP gene. ClinVar contains an entry for this variant (Variation ID: 988106). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CD46 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects CD46 function (PMID: 16762990). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at